.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Fuji
Novartis
AstraZeneca
Dow
Baxter
Harvard Business School
Chubb
McKesson
Moodys

Generated: November 23, 2017

DrugPatentWatch Database Preview

CISAPRIDE MONOHYDRATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cisapride monohydrate and what is the scope of cisapride monohydrate patent protection?

Cisapride monohydrate
is the generic ingredient in two branded drugs marketed by Janssen Pharms and Janssen Pharma, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for cisapride monohydrate.

Medical Subject Heading (MeSH) Categories for CISAPRIDE MONOHYDRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
PROPULSID
cisapride monohydrate
SUSPENSION;ORAL020398-001Sep 15, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Janssen Pharms
PROPULSID
cisapride monohydrate
TABLET;ORAL020210-002Dec 23, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Janssen Pharma
PROPULSID QUICKSOLV
cisapride monohydrate
TABLET, ORALLY DISINTEGRATING;ORAL020767-001Nov 7, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Janssen Pharms
PROPULSID
cisapride monohydrate
TABLET;ORAL020210-001Jul 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cisapride monohydrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
PROPULSID
cisapride monohydrate
TABLET;ORAL020210-001Jul 29, 1993► Subscribe► Subscribe
Janssen Pharma
PROPULSID QUICKSOLV
cisapride monohydrate
TABLET, ORALLY DISINTEGRATING;ORAL020767-001Nov 7, 1997► Subscribe► Subscribe
Janssen Pharms
PROPULSID
cisapride monohydrate
SUSPENSION;ORAL020398-001Sep 15, 1995► Subscribe► Subscribe
Janssen Pharma
PROPULSID QUICKSOLV
cisapride monohydrate
TABLET, ORALLY DISINTEGRATING;ORAL020767-001Nov 7, 1997► Subscribe► Subscribe
Janssen Pharms
PROPULSID
cisapride monohydrate
TABLET;ORAL020210-002Dec 23, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
Cipla
Healthtrust
Argus Health
Chinese Patent Office
McKesson
Daiichi Sankyo
US Army
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot